{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:08:09Z","timestamp":1789380489719,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade De Uberaba"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate patient-reported changes in orofacial and masticatory symptoms after BoNT-A application in individuals presenting bruxism-related complaints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>A retrospective cross-sectional observacional study was conducted with 61 adult participants (47 women, 14 men) who underwent BoNT-A treatment for bruxism. An online questionnaire, assessed masticatory and orofacial symptoms before and after treatment, using a five-point frequency scale. Data were analyzed with descriptive statistics, paired t-tests, and Spearman\u2019s correlation (p\u2009&lt;\u20090.05). This observational study was reported in accordance with the STROBE guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A statistically significant reduction in total symptom scores was observed after treatment (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), with a mean decrease from 32.4\u2009\u00b1\u200911.5 (before) to 15.6\u2009\u00b1\u20096.59 (after), representing an overall reduction of approximately 52%. No significant differences in symptom improvement were observed between sexes or in relation to age. Although an overall difference among professional categories was identified, post hoc analysis did not show significant pairwise differences between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Individuals with bruxism-related complaints reported improvement in pain-related and masticatory symptoms after BoNT-A application. BoNT-A may represent a supportive approach for managing orofacial and muscle-related complaints; however, further studies with standardized diagnostic criteria and objective outcome measures are needed to clarify its long-term clinical effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>BoNT-A application may contribute to the management of pain-related and masticatory complaints reported by individuals with bruxism-related symptoms, supporting its potential use as an adjunctive approach in selected clinical situations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00784-026-07070-9","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T02:41:38Z","timestamp":1786156898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perception of patients with temporomandibular disorders of the effects of botulinum toxin application: a retrospective cross-sectional observational study"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9556-0822","authenticated-orcid":false,"given":"Franco Ign\u00e1ccio","family":"Mallaguti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9221-4789","authenticated-orcid":false,"given":"Jos\u00e9 Geraldo","family":"Mallaguti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1295-8193","authenticated-orcid":false,"given":"Otacilio de Paula Rodrigues","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7325-7189","authenticated-orcid":false,"given":"Brenda Moliterno","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-3937","authenticated-orcid":false,"given":"Analia Gabriella Borges Ferraz","family":"Facury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4027-1983","authenticated-orcid":false,"given":"Ana Paula Ayres","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"7070_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41415-019-0257-z","volume":"226","author":"J Patel","year":"2019","unstructured":"Patel J, Cardoso JA, Mehta S (2019) A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism. Br Dent J 226:667\u2013672. https:\/\/doi.org\/10.1038\/s41415-019-0257-z","journal-title":"Br Dent J"},{"key":"7070_CR2","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.bjoms.2020.02.007","volume":"58","author":"S Thambar","year":"2020","unstructured":"Thambar S, Kulkarni S, Armstrong S, Nikolarakos D (2020) Botulinum toxin in the management of temporomandibular disorders: a systematic review. Br J Oral Maxillofac Surg 58:508\u2013519. https:\/\/doi.org\/10.1016\/j.bjoms.2020.02.007","journal-title":"Br J Oral Maxillofac Surg"},{"key":"7070_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/S40902-016-0051-7","volume":"38","author":"HS Kim","year":"2016","unstructured":"Kim HS, Yun PY, Kim YK (2016) A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment. Maxillofac Plast Reconstr Surg 38:5. https:\/\/doi.org\/10.1186\/S40902-016-0051-7","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"7070_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2842.2012.02298.x","volume":"39","author":"F Lobbezoo","year":"2012","unstructured":"Lobbezoo F, Ahlberg J, Manfredini D, Winocur E (2012) Are bruxism and the bite causally related? J Oral Rehabil 39:489\u2013501. https:\/\/doi.org\/10.1111\/j.1365-2842.2012.02298.x","journal-title":"J Oral Rehabil"},{"key":"7070_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/toxins12020112","volume":"12","author":"MA Serrera-Figallo","year":"2020","unstructured":"Serrera-Figallo MA, Ruiz-De-Le\u00f3n-Hern\u00e1ndez G, Torres-Lagares D, Castro-Araya A, Torres-Ferrerosa O, Hern\u00e1ndez-Pacheco E et al (2020) Use of botulinum toxin in orofacial clinical practice. Toxins (Basel) 12:112. https:\/\/doi.org\/10.3390\/toxins12020112","journal-title":"Toxins (Basel)"},{"key":"7070_CR6","doi-asserted-by":"publisher","first-page":"6264146","DOI":"10.1155\/2017\/6264146","volume":"2017","author":"F Asutay","year":"2017","unstructured":"Asutay F, Atalay Y, Asutay H, Acar AH (2017) The evaluation of the clinical effects of botulinum toxin on nocturnal bruxism. Pain Res Manag 2017:6264146. https:\/\/doi.org\/10.1155\/2017\/6264146","journal-title":"Pain Res Manag"},{"key":"7070_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jormas.2018.10.007","volume":"120","author":"S Villa","year":"2019","unstructured":"Villa S, Raoul G, Machuron F, Ferri J, Nicot R (2019) Improvement in quality of life after botulinum toxin injection for temporomandibular disorder. J Stomatol Oral Maxillofac Surg 120:2\u20136. https:\/\/doi.org\/10.1016\/j.jormas.2018.10.007","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"7070_CR8","first-page":"157","volume":"18","author":"R Ataran","year":"2017","unstructured":"Ataran R, Bahramian A, Jamali Z, Pishahang V, Sadeghi Barzegani H, Sarbakhsh P et al (2017) The role of botulinum toxin A in treatment of temporomandibular joint disorders: a review. J Dent (Tehran) 18:157\u2013164","journal-title":"J Dent (Tehran)"},{"key":"7070_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/joor.12663","volume":"45","author":"F Lobbezoo","year":"2018","unstructured":"Lobbezoo F, Ahlberg J, Raphael KG et al (2018) International consensus on the assessment of bruxism: report of a work in progress. J Oral Rehabil 45:837\u2013844. https:\/\/doi.org\/10.1111\/joor.12663","journal-title":"J Oral Rehabil"},{"key":"7070_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","volume":"26","author":"KR Aoki","year":"2005","unstructured":"Aoki KR (2005) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26:785\u2013793. https:\/\/doi.org\/10.1016\/j.neuro.2005.01.017","journal-title":"Neurotoxicology"},{"key":"7070_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pneurobio.2014.06.001","volume":"119\u2013120","author":"I Matak","year":"2014","unstructured":"Matak I, Lackovi\u0107 Z (2014) Botulinum toxin A, brain and pain. Prog Neurobiol 119\u2013120:39\u201359. https:\/\/doi.org\/10.1016\/j.pneurobio.2014.06.001","journal-title":"Prog Neurobiol"},{"key":"7070_CR12","doi-asserted-by":"publisher","first-page":"174480692412750","DOI":"10.1177\/17448069241275099","volume":"20","author":"S Hosseindoost","year":"2024","unstructured":"Hosseindoost S, Askari Rad M, Inanloo SH, Rahimi M, Dehghan S, Orandi A et al (2024) The analgesic effects of botulinum neurotoxin by modulating pain-related receptors: a literature review. Mol Pain 20:17448069241275099. https:\/\/doi.org\/10.1177\/17448069241275099","journal-title":"Mol Pain"},{"key":"7070_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1186\/s12903-025-06990-4","volume":"25","author":"N Sawadsopanont","year":"2025","unstructured":"Sawadsopanont N, Arunakul K, Tantipoj C (2025) Facial volume reduction and masticatory function after masseter botulinum toxin injection: a prospective study. BMC Oral Health 25:1595. https:\/\/doi.org\/10.1186\/s12903-025-06990-4","journal-title":"BMC Oral Health"},{"key":"7070_CR14","doi-asserted-by":"publisher","first-page":"e32180","DOI":"10.7759\/cureus.32180","volume":"14","author":"ZG Shehri","year":"2022","unstructured":"Shehri ZG, Alkhouri I, Hajeer MY, Haddad I, Abu Hawa MH (2022) Evaluation of the efficacy of low-dose botulinum toxin injection into the masseter muscle for the treatment of nocturnal bruxism: a randomized controlled clinical trial. Cureus 14:e32180. https:\/\/doi.org\/10.7759\/cureus.32180","journal-title":"Cureus"},{"key":"7070_CR15","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1007\/s00784-019-03026-4","volume":"23","author":"G De la Torre Canales","year":"2019","unstructured":"De la Torre Canales G, Poluha RL, Lora VM, Ara\u00fajo Oliveira Ferreira DM, Stuginski-Barbosa J, Bonjardim LR et al (2019) Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects? Clin Oral Investig 23:3411\u20133421. https:\/\/doi.org\/10.1007\/s00784-019-03026-4","journal-title":"Clin Oral Investig"},{"key":"7070_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/ors.12473","volume":"13","author":"FP Kapos","year":"2020","unstructured":"Kapos FP, Exposto FG, Oyarzo JF, Durham J (2020) Temporomandibular disorders: a review of current concepts in aetiology, diagnosis and management. Oral Surg 13:321\u2013334. https:\/\/doi.org\/10.1111\/ors.12473","journal-title":"Oral Surg"},{"key":"7070_CR17","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1177\/0022034516653743","volume":"95","author":"GD Slade","year":"2016","unstructured":"Slade GD, Ohrbach R, Greenspan JD, Fillingim RB, Bair E, Sanders AE et al (2016) Painful temporomandibular disorder. J Dent Res 95:1084\u20131092. https:\/\/doi.org\/10.1177\/0022034516653743","journal-title":"J Dent Res"},{"key":"7070_CR18","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/joor.14006","volume":"52","author":"F Moustafa","year":"2025","unstructured":"Moustafa F, Nishiyama A, Ishiyama H, Fueki K (2025) The relationship between work-related stress and temporomandibular disorders-related symptoms in Japanese working population. J Oral Rehabil 52:1583\u20131590. https:\/\/doi.org\/10.1111\/joor.14006","journal-title":"J Oral Rehabil"},{"key":"7070_CR19","doi-asserted-by":"publisher","first-page":"e41915","DOI":"10.1097\/MD.0000000000041915","volume":"104","author":"Z Wu","year":"2025","unstructured":"Wu Z, Lin Y, Lin Y (2025) Impact of age on degenerative joint disease of the temporomandibular joint: a systematic review and meta-analysis. Med (Baltim) 104:e41915. https:\/\/doi.org\/10.1097\/MD.0000000000041915","journal-title":"Med (Baltim)"},{"key":"7070_CR20","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/joor.13648","volume":"51","author":"K Li","year":"2024","unstructured":"Li K, Tan K, Yacovelli A, Bi WG (2024) Effect of botulinum toxin type A on muscular temporomandibular disorder: a systematic review and meta-analysis of randomized controlled trials. J Oral Rehabil 51:886\u2013897. https:\/\/doi.org\/10.1111\/joor.13648","journal-title":"J Oral Rehabil"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-026-07070-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-026-07070-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-026-07070-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:49:12Z","timestamp":1789379352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-026-07070-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["7070"],"URL":"https:\/\/doi.org\/10.1007\/s00784-026-07070-9","relation":{},"ISSN":["1436-3771"],"issn-type":[{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Ethics Committee of (CEP \u2013 Brazil), CAAE 77836524.1.0000.5145. All participants provided informed consent prior to their inclusion in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"380"}}